drugset / Trial / NCT01346982
Drug Interactions Between Silimarine and Darunavir/Ritonavir
Phase 4
Completed
15 enrolled
Fight AIDS and Infectious Diseases Foundation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · collabIrsiCaixa · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical trial to characterize drug interactions between silimarine and the protease inhibitor darunavir/ritonavir.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darunavir | Small molecule | 600 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |
| Subject | Silimarine | Unknown | 150 mg | — |